Add BrightSurf on Google Email

Rockefeller University Press


T-bet tackles hepatitis

High levels of T-bet in CD8+ T cells are prevalent in individuals who successfully fight off hepatitis infections. The protein is linked to the production of antiviral molecules like interferon and the ability of CD8+ T cells to multiply in response to the virus.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateSep 15, 2014

How bacteria battle fluoride

Recent studies have uncovered the mechanisms that allow bacteria to battle fluoride toxicity. Researchers found that bacteria use two types of proteins, fluoride/hydrogen antiporters and passive channels like Fluc, to rid themselves of unwanted fluoride. This knowledge could lead to new treatments for harmful bacterial diseases.

SourceRockefeller University Press·JournalJournal of General Physiology·DateSep 11, 2014

Tackling liver injury

A novel complement inhibitor has been found to reduce liver cell death and stimulate post-surgery liver regrowth in mice. The treatment increased survival rates from 0% to 70% even after removing up to 90% of the liver. This breakthrough could represent a new treatment strategy for various liver injuries in humans.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateAug 11, 2014

Sugary bugs subvert antibodies

Researchers discovered that a specific type of IgG2 antibody protects Pseudomonas aeruginosa by binding to extra-long sugars on the bacterial surface. This protection can lead to reduced antibacterial capacity and worsened disease outcomes in immunized individuals.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateAug 11, 2014

Healing the heart with fat

Researchers discovered that a particular EPA metabolite, 18-hydroxyeicosapentaenoic acid (18-HEPE), plays a crucial role in protecting against cardiovascular diseases. This metabolite was produced by immune cells and confirmed its heart-protective effects.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateJul 21, 2014

How sperm get into the zona

Researchers have uncovered a key biological interaction that occurs during fertilization, identifying the protein in the zona pellucida that sperm latch onto. The study found that ZP2 is essential for sperm binding, and its absence leads to sterility in female mice.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateJun 16, 2014

How cone snail venom minimizes pain

Researchers have discovered how cone snail venom Vc1.1 works to reduce neuropathic pain by targeting specific calcium channels in neurons. This breakthrough could lead to the development of synthetic versions of Vc1.1 to treat certain types of chronic pain.

SourceRockefeller University Press·JournalJournal of General Physiology·DateMay 14, 2014

A stable model for an unstable target

Singlet oxygen modifies target molecules through precise location and monitoring its effects on HCN channels in open and closed states. The findings introduce a method for further exploration of singlet oxygen's role in biological processes, including memory, heart rate, pain sensation, and cancer development.

SourceRockefeller University Press·JournalJournal of General Physiology·DateApr 14, 2014

p53 cuts off invading cancer cells

Researchers discovered that p53 acts to prevent cancer cell invasion by initiating a chain of events that ultimately prevents the formation of lamellipodia. This process involves the activation of a mitochondrial protease called Omi, which cleaves actin filaments and suppresses the activity of focal adhesion signaling protein p130Cas.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateMar 24, 2014

Gut microbes spur development of bowel cancer

A study published in The Journal of Experimental Medicine reveals that gut microbes contribute to the development of intestinal tumors, leading to colorectal cancer. Disrupting gut bacteria with antibiotics prevented polyp formation in mice, suggesting a link between inflammation and tumor growth.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateMar 3, 2014

Protecting the skin from sun exposure

Researchers have identified a specific protein involved in mediating the skin's response to UVR and found that the signal transduction cascade resembles a light-activated pathway in the eye. This new insight into the molecular pathway underlying UVR detection could lead to improved sun protection methods.

SourceRockefeller University Press·JournalJournal of General Physiology·DateJan 27, 2014

A trigger for muscular diseases

Researchers found that increasing titin's stiffness can be a trigger for pathological changes in skeletal muscles. The team used a mouse model lacking nine titin Ig domains to investigate the effects of increased stiffness, revealing that this can lead to muscle atrophy and contractility changes.

SourceRockefeller University Press·JournalJournal of General Physiology·DateJan 27, 2014

Aging cells unravel their DNA

Senescent cells, a key mechanism of aging, have been identified by researchers. They found that satellite DNA unravels as cells enter senescence, leading to cell division inhibition. This discovery could lead to new treatments for cancer and age-related diseases like Progeria.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateDec 16, 2013

Killer cocktail fights brain cancer

Researchers at Rockefeller University Press develop a novel two-pronged approach to combat glioblastoma, a highly aggressive form of brain cancer. By combining interleukin-12 with a CTLA-4 blocking drug, the cocktail successfully eradicated tumors in mice, showing promise for future treatment.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateNov 25, 2013

Controlling our circadian rhythms

A new study in The Journal of General Physiology has shed light on the biophysical processes underlying regulation of circadian rhythms. Researchers found that decreased BK channel activity, particularly a specific variant containing SRKR, contributes to reduced SCN neuron excitability during the day.

SourceRockefeller University Press·JournalJournal of General Physiology·DateNov 25, 2013

Battling defiant leukemia cells

A study finds that chronic myeloid leukemia cells with activating beta-catenin mutations are highly aggressive and resistant to Imatinib. Combined treatment with drugs restoring IRF8 expression and inactivating beta-catenin may prevent fatal leukemia progression.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateOct 7, 2013

Researchers explore PKC role in lung disease

A new study investigates the role of protein kinase C (PKC) in airway smooth muscle contraction, revealing its potential as a therapeutic target for treating asthma and chronic obstructive pulmonary disease (COPD). The research suggests that PKC activation could contribute to airway hyperresponsiveness and exacerbate lung diseases.

SourceRockefeller University Press·JournalJournal of General Physiology·DateFeb 25, 2013

Enzyme helps cancer cells avoid genetic instability

Researchers found that cancer cells lacking BRCA1 compensate by reducing 53BP1 levels, which allows them to resume homologous recombination and grow. The study suggests a new pathway for how breast cancer cells lose 53BP1, enabling resistance to chemotherapy and potentially identifying patients who respond to cathepsin inhibitors.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateJan 21, 2013

Surviving sepsis with LECT2

A recent study published in The Journal of Experimental Medicine found that patients with sepsis had abnormally low levels of the inflammatory protein LECT2. Injecting LECT2 into septic mice promoted bacterial clearance by immune cells and increased their production of survival-promoting factors.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateDec 17, 2012